Cargando…

Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis

Onychomycosis is the main cause of toenail disorders and is produced by a fungal infection. It is becoming more prevalent because of new lifestyles and immunosuppression statuses. The therapeutic approach to onychomycosis is under considerable study because of the lengthy treatments that require str...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcos-Tejedor, Félix, Santos-Carnicero, Natividad, Mayordomo, Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706868/
https://www.ncbi.nlm.nih.gov/pubmed/34948980
http://dx.doi.org/10.3390/ijerph182413371
_version_ 1784622297010667520
author Marcos-Tejedor, Félix
Santos-Carnicero, Natividad
Mayordomo, Raquel
author_facet Marcos-Tejedor, Félix
Santos-Carnicero, Natividad
Mayordomo, Raquel
author_sort Marcos-Tejedor, Félix
collection PubMed
description Onychomycosis is the main cause of toenail disorders and is produced by a fungal infection. It is becoming more prevalent because of new lifestyles and immunosuppression statuses. The therapeutic approach to onychomycosis is under considerable study because of the lengthy treatments that require strong patient commitment, the limited efficacy of treatments, the inclusion of active substances that can be hepatotoxic and cause pharmacological interactions, and/or the questionable efficacy of treatments due to a lack of clinical trials. This study responds to the demand for rapid treatment with minimal pharmacological interactions. Methods: The efficacy of nitric acid 60% treatment in patients with onychomycosis was monitored and studied. The antifungal efficacy of nitric acid was measured by microbiological culture before and after treatment and the clinical evolution of nail dystrophy was quantitatively measured by monitoring with the Onychomycosis Severity Index (OSI). Results: The results show that, with the protocol used, nitric acid 60% painlessly cured 40% (microbiologic cure) of the cases treated, and in all cases, clinical improvement was observed (p = 0.011). Conclusions: The treatment with nitric acid 60% is as efficient as conventional treatments, requires less patient compliance of the treatment and produces no pharmacological interactions, providing alternative treatment in the case of hepatotoxicity.
format Online
Article
Text
id pubmed-8706868
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87068682021-12-25 Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis Marcos-Tejedor, Félix Santos-Carnicero, Natividad Mayordomo, Raquel Int J Environ Res Public Health Article Onychomycosis is the main cause of toenail disorders and is produced by a fungal infection. It is becoming more prevalent because of new lifestyles and immunosuppression statuses. The therapeutic approach to onychomycosis is under considerable study because of the lengthy treatments that require strong patient commitment, the limited efficacy of treatments, the inclusion of active substances that can be hepatotoxic and cause pharmacological interactions, and/or the questionable efficacy of treatments due to a lack of clinical trials. This study responds to the demand for rapid treatment with minimal pharmacological interactions. Methods: The efficacy of nitric acid 60% treatment in patients with onychomycosis was monitored and studied. The antifungal efficacy of nitric acid was measured by microbiological culture before and after treatment and the clinical evolution of nail dystrophy was quantitatively measured by monitoring with the Onychomycosis Severity Index (OSI). Results: The results show that, with the protocol used, nitric acid 60% painlessly cured 40% (microbiologic cure) of the cases treated, and in all cases, clinical improvement was observed (p = 0.011). Conclusions: The treatment with nitric acid 60% is as efficient as conventional treatments, requires less patient compliance of the treatment and produces no pharmacological interactions, providing alternative treatment in the case of hepatotoxicity. MDPI 2021-12-19 /pmc/articles/PMC8706868/ /pubmed/34948980 http://dx.doi.org/10.3390/ijerph182413371 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Marcos-Tejedor, Félix
Santos-Carnicero, Natividad
Mayordomo, Raquel
Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis
title Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis
title_full Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis
title_fullStr Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis
title_full_unstemmed Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis
title_short Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis
title_sort preliminary evidence of the efficacy of nitric acid treatment in onychomycosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706868/
https://www.ncbi.nlm.nih.gov/pubmed/34948980
http://dx.doi.org/10.3390/ijerph182413371
work_keys_str_mv AT marcostejedorfelix preliminaryevidenceoftheefficacyofnitricacidtreatmentinonychomycosis
AT santoscarniceronatividad preliminaryevidenceoftheefficacyofnitricacidtreatmentinonychomycosis
AT mayordomoraquel preliminaryevidenceoftheefficacyofnitricacidtreatmentinonychomycosis